This content is from: Premium

These Health Care Funds Had a Rough Quarter

Perceptive, Casdin, and others started the year with losses after posting explosive results in 2020.

Several hedge funds in what has been one of the hottest sectors suffered a setback in the first quarter.At least four funds that specialize in life sciences or biopharma stocks posted losses for the three-month period, even as the S&P 500 index rose 6.2 percent, including dividends reinvested.For many of

To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.

Related Content